About 200 reports

‘Metastatic Colorectal Cancer (mCRC) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Metastatic Colorectal Cancer (mCRC) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Geographies Covered •...

  • Colorectal Cancer
  • United States
  • Spain
  • Japan
  • Germany
  • Italy
  • France
  • United Kingdom

‘Biliary Tract Cancer (BTC) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of biliary tract cancer in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5...

  • Cancer
  • United States
  • Spain
  • Germany
  • Italy
  • France
  • Japan
  • United Kingdom

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted NMIBC epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Non-muscle Invasive Bladder Cancer (NMIBC) Understanding Non-muscle...

  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted NMIBC epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Non-muscle Invasive Bladder Cancer (NMIBC) Understanding Non-muscle...

  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy

Colorectal Cancer:

  • Colorectal Cancer
  • China
  • Japan
  • France
  • Germany
  • Spain
  • World
  • Cancer Incidence
  • Smoking Prevalence

‘Anaplastic lymphoma kinase-Non Small Cell Lung Cancer (ALK-NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted ALK NSCLCepidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Anaplastic...

  • Lung Cancer
  • Germany
  • Spain
  • Japan
  • United States
  • France
  • Italy
  • United Kingdom

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted PD-L1 NSCLC epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. PD-L1...

  • Lung Cancer
  • Germany
  • Spain
  • Japan
  • United States
  • France
  • Italy
  • United Kingdom

‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted BRAF Mutated NSCLC epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. BRAF Mutated NSCLC...

  • Lung Cancer
  • France
  • Germany
  • United Kingdom
  • Spain
  • Japan
  • United States
  • Italy

‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted c-Met Mutated NSCLC epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom),...

  • Lung Cancer
  • France
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • United States
  • Italy

‘Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the PD-L1 NSCLC ,historical and forecasted epidemiology as well as the PD-L1 NSCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United...

  • Lung Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Health Expenditure
  • Use Of Prescription Drugs

‘Biliary Tract Cancer (BTC)– Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of biliary tract cancer (BTC) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The biliary tract...

  • Cancer
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure

‘Hot Flashes Associated with Prostate Cancer Treatment—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Hot Flashes Associated with Prostate Cancer Treatment in the United States, EU5 (Germany, Spain, Italy,...

  • Prostate Cancer
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy

‘Neoantigen-based Personalized Cancer therapeutic Vaccines-Competitive Landscape and Market Forecast—by 2035’ report delivers an in-depth understanding of the Neoantigen based Personalized Cancer therapeutic Vaccines and the Neoantigen-based personalized cancer therapeutic vaccines emerging market trends in the United States, EU5 (Germany,...

  • Cancer
  • Japan
  • United States
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Zhejiang
  • Health Expenditure

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the NMIBC, historical and forecasted epidemiology as well as the NMIBC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The NMIBC market report...

  • Therapy
  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Drug Approval
  • Health Expenditure

‘Non-muscle Invasive Bladder Cancer (NMIBC)—Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the NMIBC, historical and forecasted epidemiology as well as the NMIBC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The NMIBC market report...

  • Therapy
  • Bladder Cancer
  • United States
  • Japan
  • Germany
  • United Kingdom
  • Spain
  • France
  • Italy
  • Drug Approval
  • Health Expenditure

‘Hormone Receptor (HR) positive/ Human Epidermal Receptor 2 (HER2) negative Breast Cancer-Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the HR-positive/ HER2-negative breast cancer, historical and forecasted epidemiology as well as the HR-positive/ HER2-negative breast cancer market trends...

  • Breast Cancer
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Japan
  • Health Expenditure

‘Gastro-esophageal Adenocarcinoma-Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Gastro-esophageal Adenocarcinoma, historical and forecasted epidemiology as well as the Gastro-esophageal Adenocarcinoma trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Gastro-esophageal...

  • Lung Cancer
  • Germany
  • United States
  • United Kingdom
  • Spain
  • France
  • Italy
  • Japan

INTRODUCTION The introduction of personalized medicine has brought about a paradigm shift within the healthcare sector. Over the years, many cases have been identified where conventional treatment options have failed to demonstrate any therapeutic benefit. It is estimated that nearly 50% of prescribed drugs / therapies...

  • Diagnostics
  • Molecular Diagnostics
  • Cancer
  • Europe
  • China
  • North America
  • Australia
  • Japan
  • United States
  • APAC
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom

This new report from VPGMarketResearch contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:  Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

  • Diagnostic Imaging
  • Diagnostics
  • Lymphoma
  • Leukemia
  • Spain

2019-2023 Spain Hospital Tumor Marker Testing Market: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review This new report contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:  Major...

  • Diagnostic Imaging
  • Diagnostics
  • Lymphoma
  • Leukemia
  • Spain

‘Severe Toxicities in Lymphoma - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Severe Toxicities in Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Severe Toxicities in Lymphoma Understanding Lymphoma...

  • Lymphoma
  • Germany
  • Spain
  • France
  • Italy
  • United Kingdom
  • United States
  • World
  • Japan

“177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Prostate cancer in 7 Major Markets. A detailed picture of the 177-LUTETIUM-PSMA-617 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom),...

  • Rare Earth
  • Prostate Cancer
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

“Seviteronel- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Prostate cancer in 7 Major Markets. A detailed picture of the Seviteronel in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the...

  • Prostate Cancer
  • Research And Development
  • Clinical Trial
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Overview “Kadcyla - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kadcyla in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Clinical Trial
  • Breast Cancer
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure
  • Drug Approval

“HC 1119- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Prostate cancer in 7 Major Markets. A detailed picture of the HC 1119 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...

  • Prostate Cancer
  • Research And Development
  • Clinical Trial
  • Europe
  • World
  • Japan
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • China
  • Health Expenditure

“ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. A detailed picture of the ATEZOLIZUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom),...

  • Lymphoma
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Overview “Enhertu - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Enhertu in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Clinical Trial
  • Breast Cancer
  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure

Overview “Nerlynx - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Nerlynx in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Clinical Trial
  • Breast Cancer
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure

‘Glioblastoma Multiforme (GBM) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Glioblastoma Multiforme (GBM) Understanding Glioblastoma...

  • Brain Cancer
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Japan

‘Multiple Myeloma (MM)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted MM epidemiology in the 8MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, and China. Multiple Myeloma (MM) Understanding According...

  • Cancer
  • China
  • United States
  • Germany
  • Japan
  • Spain
  • France
  • Italy
  • United Kingdom